In G(alpha)q mice, myocyte-specific overexpression of catalase prevented the progressive remodeling phase leading to heart failure, including myocyte hypertrophy, apoptosis, and interstitial fibrosis.
Does myocyte-specific overexpression of catalase prevent myocardial remodeling and progression to heart failure in G(alpha)q-overexpressing transgenic mice?
In a transgenic mouse model of heart failure, catalase overexpression prevented progressive adverse remodeling and overt heart failure, demonstrating the critical role of hydrogen peroxide in disease progression.
BACKGROUND: Although it seems that reactive oxygen species contribute to chronic myocardial remodeling, questions remain about (1) the specific types of reactive oxygen species involved, (2) the role of reactive oxygen species in mediating specific cellular events, and (3) the cause-and-effect relationship between myocardial reactive oxygen species and the progression to heart failure. Transgenic mice with myocyte-specific overexpression of G(alpha)q develop a dilated cardiomyopathy that progresses to heart failure. We used this model to examine the role of H(2)O(2) in mediating myocardial remodeling and the progression to failure. METHODS AND RESULTS: In G(alpha)q myocardium, markers of oxidative stress were increased at 4 weeks and increased further at 20 weeks. G(alpha)q mice were crossbred with transgenic mice having myocyte-specific overexpression of catalase. At 4 weeks of age, left ventricular end-diastolic dimension was increased and left ventricular fractional shortening decreased in G(alpha)q mice and deteriorated further through 20 weeks. In G(alpha)q mice, myocardial catalase overexpression had no effect on left ventricular end-diastolic dimension or fractional shortening at 4 weeks but prevented the subsequent deterioration in both. In G(alpha)q mice, myocyte hypertrophy; myocyte apoptosis; interstitial fibrosis; and the progression to overt heart failure, as reflected by lung congestion and exercise intolerance, were prevented by catalase overexpression. CONCLUSIONS: In G(alpha)q mice, myocyte-specific overexpression of catalase had no effect on the initial phenotype of left ventricular dilation and contractile dysfunction but prevented the subsequent progressive remodeling phase leading to heart failure. Catalase prevented the cellular hallmarks of adverse remodeling (myocyte hypertrophy, myocyte apoptosis, and interstitial fibrosis) and the progression to overt heart failure. Thus, H(2)O(2), associated oxidant pathways, or both play a critical role in adverse myocardial remodeling and the progression to failure.
Qin et al. (Fri,) conducted a other in Dilated cardiomyopathy and heart failure. Myocyte-specific overexpression of catalase vs. G(alpha)q mice without catalase overexpression was evaluated on Left ventricular end-diastolic dimension, fractional shortening, and progression to overt heart failure. In G(alpha)q mice, myocyte-specific overexpression of catalase prevented the progressive remodeling phase leading to heart failure, including myocyte hypertrophy, apoptosis, and interstitial fibrosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: